Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial()

BACKGROUND: A previous analysis of the placebo arm of the Prostate Cancer Prevention Trial (PCPT) reported 82% overall prevalence of intraprostatic inflammation and identified a link between inflammation and higher-grade prostate cancer and serum PSA. Here we studied these associations in the PCPT f...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Epidemiol Biomarkers Prev
Prif Awduron: Murtola, Teemu J., Gurel, Bora, Umbehr, Martin, Lucia, M. Scott, Thompson, Ian M., Goodman, Phyllis J., Kristal, Alan R., Parnes, Howard L., Lippman, Scott M., Sutcliffe, Siobhan, Peskoe, Sarah B., Barber, John R., Drake, Charles G., Nelson, William G., De Marzo, Angelo M., Platz, Elizabeth A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4779655/
https://ncbi.nlm.nih.gov/pubmed/26715424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-15-0987
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg